{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:35:48Z","timestamp":1790548548651,"version":"4.1.0"},"reference-count":170,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.antiviral.2020.104917","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T12:33:17Z","timestamp":1597667597000},"page":"104917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"special_numbering":"C","title":["Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B"],"prefix":"10.1016","volume":"182","author":[{"given":"Usha","family":"Viswanathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagraj","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqun","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Tao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104917_bib1","doi-asserted-by":"crossref","first-page":"E2782","DOI":"10.1073\/pnas.1308846110","article-title":"Thermodynamic origins of protein folding, allostery, and capsid formation in the human hepatitis B virus core protein","volume":"110","author":"Alexander","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104917_bib2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.29509","article-title":"A research agenda for curing chronic hepatitis B virus infection","volume":"67","author":"Alter","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104917_bib3","article-title":"Novel hepatitis B virus capsid assembly modulator induces potent antiviral responses in vitro and in humanized mice","volume":"64","author":"Amblard","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104917_bib4","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1128\/JVI.75.4.2024-2028.2001","article-title":"Does a cdc2 kinase-like recognition motif on the core protein of hepadnaviruses regulate assembly and disintegration of capsids?","volume":"75","author":"Barrasa","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib5","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1002\/j.1460-2075.1992.tb05420.x","article-title":"Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome","volume":"11","author":"Bartenschlager","year":"1992","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2020.104917_bib6","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1128\/JVI.01671-06","article-title":"Regulation of hepadnavirus reverse transcription by dynamic nucleocapsid phosphorylation","volume":"81","author":"Basagoudanavar","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02439-19","article-title":"Antiviral properties and mechanism of action studies of the hepatitis B virus capsid assembly modulator JNJ-56136379","volume":"64","author":"Berke","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104917_bib8","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1128\/jvi.64.7.3319-3330.1990","article-title":"Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein","volume":"64","author":"Birnbaum","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.antiviral.2013.01.006","article-title":"Chronic hepatitis B: what should be the goal for new therapies?","volume":"98","author":"Block","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104917_bib10","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jhep.2016.02.008","article-title":"Intracellular transport and egress of hepatitis B virus","volume":"64","author":"Blondot","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104917_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/jmbi.2000.4481","article-title":"Structural organization of the hepatitis B virus minichromosome","volume":"307","author":"Bock","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2020.104917_bib12","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1016\/j.jmb.2018.10.018","article-title":"Structure of mutant hepatitis B core protein capsids with premature secretion phenotype","volume":"430","author":"Bottcher","year":"2018","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2020.104917_bib13","doi-asserted-by":"crossref","first-page":"10262","DOI":"10.1128\/JVI.01360-08","article-title":"Small-molecule effectors of hepatitis B virus capsid assembly give insight into virus life cycle","volume":"82","author":"Bourne","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib14","doi-asserted-by":"crossref","first-page":"11055","DOI":"10.1128\/JVI.00933-06","article-title":"Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1","volume":"80","author":"Bourne","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib15","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1021\/bi801814y","article-title":"A mutant hepatitis B virus core protein mimics inhibitors of icosahedral capsid self-assembly","volume":"48","author":"Bourne","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2020.104917_bib17","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1128\/JVI.00582-13","article-title":"Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids","volume":"87","author":"Campagna","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib18","doi-asserted-by":"crossref","first-page":"9538","DOI":"10.1128\/JVI.78.17.9538-9543.2004","article-title":"Hepatitis B virus capsid assembly is enhanced by naturally occurring mutation F97L","volume":"78","author":"Ceres","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib19","doi-asserted-by":"crossref","first-page":"11525","DOI":"10.1021\/bi0261645","article-title":"Weak protein\u2212 protein interactions are sufficient to drive assembly of hepatitis B virus capsids","volume":"41","author":"Ceres","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2020.104917_bib20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.apsb.2014.05.002","article-title":"Therapeutic strategies for a functional cure of chronic hepatitis B virus infection","volume":"4","author":"Chang","year":"2014","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.antiviral.2020.104917_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005802","article-title":"Importin beta can bind hepatitis B virus core protein and empty core-like particles and induce structural changes","volume":"12","author":"Chen","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104917_bib22","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1128\/jvi.66.9.5682-5684.1992","article-title":"The precore gene of the woodchuck hepatitis virus genome is not essential for viral replication in the natural host","volume":"66","author":"Chen","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2017.05.003","article-title":"Role of hepatitis B core protein in HBV transcription and recruitment of histone acetyltransferases to cccDNA minichromosome","volume":"144","author":"Chong","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104917_bib24","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1128\/JVI.03235-13","article-title":"Nucleic acid chaperone activity associated with the arginine-rich domain of human hepatitis B virus core protein","volume":"88","author":"Chu","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib25","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1128\/JVI.01666-09","article-title":"Testing the balanced electrostatic interaction hypothesis of hepatitis B virus DNA synthesis by using an in vivo charge rebalance approach","volume":"84","author":"Chua","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.coph.2016.08.004","article-title":"Modulators of HBV capsid assembly as an approach to treating hepatitis B virus infection","volume":"30","author":"Cole","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.antiviral.2020.104917_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.antiviral.2018.07.011","article-title":"Novel non-heteroarylpyrimidine (HAP) capsid assembly modifiers have a different mode of action from HAPs in vitro","volume":"158","author":"Corcuera","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104917_bib28","doi-asserted-by":"crossref","first-page":"9021","DOI":"10.1128\/JVI.01261-15","article-title":"Hepatitis B virus covalently closed circular DNA formation in immortalized mouse hepatocytes associated with nucleocapsid destabilization","volume":"89","author":"Cui","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib29","doi-asserted-by":"crossref","first-page":"10064","DOI":"10.1128\/JVI.01481-15","article-title":"Alteration of mature nucleocapsid and enhancement of covalently closed circular DNA formation by hepatitis B virus core mutants defective in complete-virion formation","volume":"89","author":"Cui","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib30","doi-asserted-by":"crossref","first-page":"11494","DOI":"10.1128\/JVI.01912-13","article-title":"Maturation-associated destabilization of hepatitis B virus nucleocapsid","volume":"87","author":"Cui","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib31","doi-asserted-by":"crossref","first-page":"8124","DOI":"10.1128\/JVI.76.16.8124-8137.2002","article-title":"Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein","volume":"76","author":"Daub","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib32","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature17170","article-title":"Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor","volume":"531","author":"Decorsiere","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104917_bib33","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.1077215","article-title":"Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids","volume":"299","author":"Deres","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2020.104917_bib34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2012.04.012","article-title":"Differential assembly of Hepatitis B Virus core protein on single- and double-stranded nucleic acid suggest the dsDNA-filled core is spring-loaded","volume":"430","author":"Dhason","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104917_bib35","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/hep.29236","article-title":"Polo-like-kinase 1 is a proviral host factor for hepatitis B virus replication","volume":"66","author":"Diab","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104917_bib36","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1002\/hep.22920","article-title":"Benefits and risks of nucleoside analog therapy for hepatitis B","volume":"49","author":"Dienstag","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104917_bib37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.str.2012.10.017","article-title":"Antigenic switching of hepatitis B virus by alternative dimerization of the capsid protein","volume":"21","author":"DiMattia","year":"2013","journal-title":"Structure"},{"issue":"1","key":"10.1016\/j.antiviral.2020.104917_bib38","article-title":"Multiple dose study of GLS4JHS, interfering with the assembly of HBV core particles, in patients infected with hepatitis B virus","volume":"66","author":"Ding","year":"2017","journal-title":"Hepatology"},{"issue":"Pt 7","key":"10.1016\/j.antiviral.2020.104917_bib39","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1099\/0022-1317-79-7-1665","article-title":"Phosphorylation of the hepatitis B virus core protein by glyceraldehyde-3-phosphate dehydrogenase protein kinase activity","volume":"79","author":"Duclos-Vallee","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/v9010021","article-title":"Nuclear import of hepatitis B virus capsids and genome","volume":"9","author":"Gallucci","year":"2017","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.antiviral.2020.104917_bib41","article-title":"JNJ-64530440 (JNJ-0440), A novel, class N capsid assembly modulator (CAM-N): safety, tolerability, pharmacokinetics and antiviral activity of multiple ascending doses in patients with chronic hepatitis B","volume":"70","author":"Gane","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104917_bib42","doi-asserted-by":"crossref","first-page":"e491","DOI":"10.1016\/S0618-8278(19)30964-8","article-title":"RO7049389, a core protein allosteric modulator, demonstrates robust decline in HBV DNA and HBV RNA in chronic HBV infected patients","volume":"70","author":"Gane","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104917_bib43","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1128\/jvi.74.10.4721-4728.2000","article-title":"Core protein phosphorylation modulates pregenomic RNA encapsidation to different extents in human and duck hepatitis B viruses","volume":"74","author":"Gazina","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib44","doi-asserted-by":"crossref","first-page":"7056","DOI":"10.1128\/jvi.70.10.7056-7061.1996","article-title":"The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice","volume":"70","author":"Guidotti","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006658","article-title":"HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways","volume":"13","author":"Guo","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104917_bib46","doi-asserted-by":"crossref","first-page":"12472","DOI":"10.1128\/JVI.01123-07","article-title":"Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation","volume":"81","author":"Guo","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1128\/JVI.01921-09","article-title":"Production and function of the cytoplasmic deproteinized relaxed circular DNA of hepadnaviruses","volume":"84","author":"Guo","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2015.08.005","article-title":"Metabolism and function of hepatitis B virus cccDNA: implications for the development of cccDNA-targeting antiviral therapeutics","volume":"122","author":"Guo","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104917_bib49","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4161\/epi.6.6.15815","article-title":"HBc binds to the CpG islands of HBV cccDNA and promotes an epigenetic permissive state","volume":"6","author":"Guo","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.antiviral.2020.104917_bib50","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.32478","article-title":"All-atom molecular dynamics of the HBV capsid reveals insights into biological function and cryo-EM resolution limits","volume":"7","author":"Hadden","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.antiviral.2020.104917_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007488","article-title":"Hepatitis B virus core protein phosphorylation: identification of the SRPK1 target sites and impact of their occupancy on RNA binding and capsid structure","volume":"14","author":"Heger-Stevic","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104917_bib52","series-title":"Hepatitis B Virus Core Protein Nuclear Interactome Identifies SRSF10 as a Host RNA-Binding Protein Restricting HBV RNA Production","author":"Helene","year":"2020"},{"key":"10.1016\/j.antiviral.2020.104917_bib53","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/acsinfecdis.8b00081","article-title":"Virological basis for the cure of chronic hepatitis B","volume":"5","author":"Hu","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104917_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/v9030056","article-title":"Complete and incomplete hepatitis B virus particles: formation, function, and application","volume":"9","author":"Hu","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2020.104917_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008669","article-title":"Protein phosphatase 1 catalyzes HBV core protein dephosphorylation and is co-packaged with viral pregenomic RNA into nucleocapsids","volume":"16","author":"Hu","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104917_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/mSphereDirect.00131-18","article-title":"The heteroaryldihydropyrimidine bay 38-7690 induces hepatitis B virus core protein aggregates associated with promyelocytic leukemia nuclear bodies in infected cells","volume":"3","author":"Huber","year":"2018","journal-title":"mSphere"},{"key":"10.1016\/j.antiviral.2020.104917_bib57","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1128\/JVI.02348-08","article-title":"Characterization of genotype-specific carboxyl-terminal cleavage sites of hepatitis B virus e antigen precursor and identification of furin as the candidate enzyme","volume":"83","author":"Ito","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib58","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1038\/s41467-019-10200-5","article-title":"Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly","volume":"10","author":"Kang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2020.104917_bib59","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.1128\/jvi.68.12.7993-8000.1994","article-title":"Effect of core protein phosphorylation by protein kinase C on encapsidation of RNA within core particles of hepatitis B virus","volume":"68","author":"Kann","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib60","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1021\/cb100275b","article-title":"Trapping of hepatitis B virus capsid assembly intermediates by phenylpropenamide assembly accelerators","volume":"5","author":"Katen","year":"2010","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.antiviral.2020.104917_bib61","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.str.2013.06.013","article-title":"Assembly-directed antivirals differentially bind quasiequivalent pockets to modify hepatitis B virus capsid tertiary and quaternary structure","volume":"21","author":"Katen","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.antiviral.2020.104917_bib62","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1128\/AAC.42.12.3179","article-title":"Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L- 2',3'-dideoxy-3'-thiacytidine","volume":"42","author":"King","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104917_bib63","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1128\/AAC.42.12.3179","article-title":"Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (\u2212) \u03b2-l-2\u2032, 3\u2032-dideoxy-3\u2032-thiacytidine","volume":"42","author":"King","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104917_bib64","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.coviro.2014.02.002","article-title":"Capsid proteins of enveloped viruses as antiviral drug targets","volume":"5","author":"Klumpp","year":"2014","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.antiviral.2020.104917_bib65","doi-asserted-by":"crossref","first-page":"15196","DOI":"10.1073\/pnas.1513803112","article-title":"High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein","volume":"112","author":"Klumpp","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104917_bib66","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01440-19","article-title":"A new role for capsid assembly modulators to target mature hepatitis B virus capsids and prevent virus infection","volume":"64","author":"Ko","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104917_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.74.1.1-7.2000","article-title":"Hepatitis B virus core gene mutations which block nucleocapsid envelopment","volume":"74","author":"Koschel","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib68","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00835-18","article-title":"Novel potent capsid assembly modulators regulate multiple steps of the Hepatitis B virus life-cycle","author":"Lahlali","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104917_bib69","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/viro.1999.9798","article-title":"Roles of the three major phosphorylation sites of hepatitis B virus core protein in viral replication","volume":"259","author":"Lan","year":"1999","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.antiviral.2020.104917_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/S0618-8278(19)30934-X","article-title":"HBcrAg decline in JNJ-56136379-treated chronic hepatitis B patients: results of a phase 1 study","volume":"70","author":"Lenz","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104917_bib71","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/JVI.01957-10","article-title":"The arginine clusters of the carboxy-terminal domain of the core protein of hepatitis B virus make pleiotropic contributions to genome replication","volume":"85","author":"Lewellyn","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017202","article-title":"Serine phosphoacceptor sites within the core protein of hepatitis B virus contribute to genome replication pleiotropically","volume":"6","author":"Lewellyn","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104917_bib73","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.28025","article-title":"Present and future therapies of hepatitis B: from discovery to cure","volume":"62","author":"Liang","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104917_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007085","article-title":"Multiple roles of core protein linker in hepatitis B virus replication","volume":"14","author":"Liu","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104917_bib75","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.30844","article-title":"Hepatitis B virus virions produced under nucleos(t)ide analogue treatment are mainly not infectious because of irreversible DNA chain termination","volume":"71","author":"Liu","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104917_bib76","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jhep.2017.05.008","article-title":"Hepatitis B cure: from discovery to regulatory approval","volume":"67","author":"Lok","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104917_bib77","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jhep.2011.02.015","article-title":"Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection","volume":"55","author":"Lucifora","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104917_bib78","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2020.104917_bib79","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1128\/JVI.00394-16","article-title":"Cell-free hepatitis B virus capsid assembly dependent on the core protein C-terminal domain and regulated by phosphorylation","volume":"90","author":"Ludgate","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib80","doi-asserted-by":"crossref","first-page":"12237","DOI":"10.1128\/JVI.01218-12","article-title":"Cyclin-dependent kinase 2 phosphorylates s\/t-p sites in the hepadnavirus core protein C-terminal domain and is incorporated into viral capsids","volume":"86","author":"Ludgate","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib81","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00539-17","article-title":"Identification of intermediate in hepatitis B virus CCC DNA formation and sensitive and selective CCC DNA detection","author":"Luo","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008459","article-title":"Role of Hepatitis B virus capsid phosphorylation in nucleocapsid disassembly and covalently closed circular DNA formation","volume":"16","author":"Luo","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104917_bib83","doi-asserted-by":"crossref","first-page":"16932","DOI":"10.1021\/jacs.7b09932","article-title":"Hepatitis B virus capsid completion occurs through error correction","volume":"139","author":"Lutomski","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2020.104917_bib84","series-title":"American Association for the Study of Liver Diseases (AASLD) Annual Meeting (The Liver Meeting). Conference Reports for NATAP, Boston, MA","article-title":"Continued therapy with ABI-H0731 + NrtI results in sequential reduction\/loss of HBV DNA, HBV RNA, HBeAg, HBcrAg and HBsAg in HBeAg-positive patients","author":"Mark","year":"2019"},{"key":"10.1016\/j.antiviral.2020.104917_bib85","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1073\/pnas.79.13.3997","article-title":"Asymmetric replication of duck hepatitis B virus DNA in liver cells: free minus-strand DNA","volume":"79","author":"Mason","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104917_bib86","doi-asserted-by":"crossref","first-page":"9810","DOI":"10.1128\/JVI.79.15.9810-9820.2005","article-title":"Hepatitis B virus DNA replication is coordinated by core protein serine phosphorylation and HBx expression","volume":"79","author":"Melegari","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib87","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1080\/21645515.2019.1607132","article-title":"Is the function of the HBeAg really unknown?","volume":"15","author":"Milich","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2020.104917_bib88","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00196-19","article-title":"Hepatitis B virus precore protein p22 inhibits alpha interferon signaling by blocking STAT nuclear translocation","volume":"93","author":"Mitra","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib89","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1128\/jvi.66.7.4107-4116.1992","article-title":"The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly","volume":"66","author":"Nassal","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib90","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cbpa.2019.02.009","article-title":"Recent advances in the development of HBV capsid assembly modulators","volume":"50","author":"Nijampatnam","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.antiviral.2020.104917_bib91","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00092-17","article-title":"Capsid phosphorylation state and hepadnavirus virion secretion","volume":"91","author":"Ning","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib92","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00272-18","article-title":"Common and distinct capsid and surface protein requirements for secretion of complete and genome-free hepatitis B virions","volume":"92","author":"Ning","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002255","article-title":"Secretion of genome-free hepatitis B virus--single strand blocking model for virion morphogenesis of para-retrovirus","volume":"7","author":"Ning","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104917_bib94","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1248\/bpb.29.1810","article-title":"Biochemical characterization of suramin as a selective inhibitor for the PKA-mediated phosphorylation of HBV core protein in vitro","volume":"29","author":"Okabe","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.antiviral.2020.104917_bib95","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.0c03569","article-title":"Assembly of capsids from hepatitis B virus core protein progresses through highly populated intermediates in presence and absence of RNA","author":"Oliver","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.antiviral.2020.104917_bib96","doi-asserted-by":"crossref","first-page":"9281","DOI":"10.1128\/JVI.00466-15","article-title":"An aptamer against the matrix binding domain on the hepatitis B virus capsid impairs virion formation","volume":"89","author":"Orabi","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib97","article-title":"The chaperone dynein LL1 mediates cytoplasmic transport of empty and mature hepatitis B virus capsids","author":"Osseman","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104917_bib98","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1128\/JVI.02033-09","article-title":"Conformational changes in the hepatitis B virus core protein are consistent with a role for allostery in virus assembly","volume":"84","author":"Packianathan","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib99","doi-asserted-by":"crossref","first-page":"11616","DOI":"10.1128\/JVI.01178-09","article-title":"Functional surfaces of the hepatitis B virus capsid","volume":"83","author":"Pairan","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib100","doi-asserted-by":"crossref","first-page":"9020","DOI":"10.1073\/pnas.0502138102","article-title":"Reverse transcription-associated dephosphorylation of hepadnavirus nucleocapsids","volume":"102","author":"Perlman","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104917_bib101","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev-physchem-040214-121637","article-title":"Mechanisms of virus assembly","volume":"66","author":"Perlmutter","year":"2015","journal-title":"Annu. Rev. Phys. Chem."},{"key":"10.1016\/j.antiviral.2020.104917_bib102","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1002\/hep.22956","article-title":"Benefits and risks of interferon therapy for hepatitis B","volume":"49","author":"Perrillo","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104917_bib103","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2468-1253(18)30056-6","article-title":"Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study","volume":"3","author":"Polaris Observatory","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.antiviral.2020.104917_bib104","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1128\/JVI.77.1.416-422.2003","article-title":"Mapping of amino acid side chains on the surface of hepatitis B virus capsids required for envelopment and virion formation","volume":"77","author":"Ponsel","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib105","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1128\/jvi.63.3.1371-1376.1989","article-title":"Characterization of the major duck hepatitis B virus core particle protein","volume":"63","author":"Pugh","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib106","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1021\/acschembio.8b00283","article-title":"An assembly-activating site in the hepatitis B virus capsid protein can also trigger disassembly","volume":"13","author":"Qazi","year":"2018","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.antiviral.2020.104917_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005893","article-title":"DNA polymerase kappa is a key cellular factor for the formation of covalently closed circular DNA of hepatitis B virus","volume":"12","author":"Qi","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104917_bib108","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.1021\/acs.jmedchem.6b00879","article-title":"Design and synthesis of orally bioavailable 4-methyl heteroaryldihydropyrimidine based hepatitis B virus (HBV) capsid inhibitors","volume":"59","author":"Qiu","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2020.104917_bib109","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1128\/jvi.61.4.955-961.1987","article-title":"In vivo phosphorylation and protein analysis of hepatitis B virus core antigen","volume":"61","author":"Roossinck","year":"1987","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib110","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01082-18","article-title":"Assembly properties of Hepatitis B Virus core protein mutants correlate with their resistance to assembly-directed antivirals","author":"Ruan","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib111","doi-asserted-by":"crossref","first-page":"11540","DOI":"10.1128\/JVI.01745-14","article-title":"Characterization of the mode of action of a potent dengue virus capsid inhibitor","volume":"88","author":"Scaturro","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib112","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31473","article-title":"Hepatitis B virus core protein allosteric modulators can distort and disrupt intact capsids","volume":"7","author":"Schlicksup","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.antiviral.2020.104917_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000741","article-title":"Nucleoporin 153 arrests the nuclear import of hepatitis B virus capsids in the nuclear basket","volume":"6","author":"Schmitz","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104917_bib114","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1128\/JVI.73.7.5459-5465.1999","article-title":"Elimination of duck hepatitis B virus RNA-containing capsids in duck interferon-alpha-treated hepatocytes","volume":"73","author":"Schultz","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib115","doi-asserted-by":"crossref","first-page":"28584","DOI":"10.1074\/jbc.M115.678441","article-title":"Hepatitis B virus core protein phosphorylation sites affect capsid stability and transient exposure of the C-terminal domain","volume":"290","author":"Selzer","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2020.104917_bib116","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02230-18","article-title":"Cellular DNA topoisomerases are required for the synthesis of hepatitis B virus covalently closed circular DNA","author":"Sheraz","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib117","series-title":"Healthy Subjects (HS) and Chronic Hepatitis B (CHB) Subjects","article-title":"Key findings leading to the discontinuation of a Capsid Inhibitor (CI), AB-506","author":"Sims","year":"2019"},{"key":"10.1016\/j.antiviral.2020.104917_bib118","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1073\/pnas.0409732102","article-title":"A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly","volume":"102","author":"Stray","year":"2005","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.antiviral.2020.104917_bib119","doi-asserted-by":"crossref","first-page":"8138","DOI":"10.1073\/pnas.0409732102","article-title":"A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly","volume":"102","author":"Stray","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104917_bib120","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/jmr.801","article-title":"BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly","volume":"19","author":"Stray","year":"2006","journal-title":"J. Mol. Recogn."},{"key":"10.1016\/j.antiviral.2020.104917_bib121","doi-asserted-by":"crossref","first-page":"38959","DOI":"10.1038\/srep38959","article-title":"HBV maintains electrostatic homeostasis by modulating negative charges from phosphoserine and encapsidated nucleic acids","volume":"6","author":"Su","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.antiviral.2020.104917_bib122","article-title":"Continued therapy with ABI-H0731 + NrtI results in sequential reduction\/loss of HBV DNA, HBV RNA, HBeAg, HBcrAg and HBsAg in HBeAg-positive patients","volume":"70","author":"Sulkowski","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104917_bib123","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0092-8674(82)90157-X","article-title":"Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate","volume":"29","author":"Summers","year":"1982","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2020.104917_bib124","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1128\/jvi.64.6.2819-2824.1990","article-title":"Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification","volume":"64","author":"Summers","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib125","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1128\/JVI.03014-12","article-title":"Genetically altering the thermodynamics and kinetics of hepatitis B virus capsid assembly has profound effects on virus replication in cell culture","volume":"87","author":"Tan","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib126","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1128\/JVI.03545-14","article-title":"The interface between hepatitis B virus capsid proteins affects self-assembly, pregenomic RNA packaging, and reverse transcription","volume":"89","author":"Tan","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007742","article-title":"DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA","volume":"15","author":"Tang","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104917_bib128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/17460441.2017.1255195","article-title":"The current status and future directions of hepatitis B antiviral drug discovery","volume":"12","author":"Tang","year":"2017","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.antiviral.2020.104917_bib129","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1128\/jvi.68.6.3536-3543.1994","article-title":"Hepadnavirus reverse transcription initiates within the stem-loop of the RNA packaging signal and employs a novel strand transfer","volume":"68","author":"Tavis","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib130","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.immuni.2016.04.008","article-title":"Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission","volume":"44","author":"Tian","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2020.104917_bib131","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(86)90602-1","article-title":"Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells","volume":"47","author":"Tuttleman","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2020.104917_bib132","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1007\/s12325-019-01017-1","article-title":"Pharmacokinetics, safety and tolerability of JNJ-56136379, a novel hepatitis B virus capsid assembly modulator, in healthy subjects","volume":"36","author":"Vandenbossche","year":"2019","journal-title":"Adv. Ther."},{"key":"10.1016\/j.antiviral.2020.104917_bib133","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/JVI.03058-15","article-title":"Hepatitis B virus capsids have diverse structural responses to small-molecule ligands bound to the heteroaryldihydropyrimidine pocket","volume":"90","author":"Venkatakrishnan","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib134","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-virology-110615-042238","article-title":"The structural biology of hepatitis B virus: form and function","volume":"3","author":"Venkatakrishnan","year":"2016","journal-title":"Ann. Rev. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib135","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.1128\/jvi.67.11.6507-6512.1993","article-title":"Novel mechanism for reverse transcription in hepatitis B viruses","volume":"67","author":"Wang","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib136","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1128\/AAC.01558-15","article-title":"A novel pyridazinone derivative inhibits hepatitis B virus replication by inducing genome-free capsid formation","volume":"59","author":"Wang","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104917_bib137","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1021\/bi00015a003","article-title":"Hepatitis core antigen produced in Escherichia coli: subunit composition, conformation analysis, and in vitro capsid assembly","volume":"34","author":"Wingfield","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2020.104917_bib138","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1462-5822.2010.01444.x","article-title":"Inhibition of protein kinase C phosphorylation of hepatitis B virus capsids inhibits virion formation and causes intracellular capsid accumulation","volume":"12","author":"Wittkop","year":"2010","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.antiviral.2020.104917_bib139","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1128\/AAC.01091-13","article-title":"Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly","volume":"57","author":"Wu","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104917_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2018.09.001","article-title":"CpAMs induce assembly of HBV capsids with altered electrophoresis mobility: implications for mechanism of inhibiting pgRNA packaging","volume":"159","author":"Wu","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104917_bib141","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00519-17","article-title":"Discovery and mechanistic study of benzamide derivatives that modulate hepatitis B virus capsid assembly","volume":"91","author":"Wu","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib142","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1097-2765(01)80009-5","article-title":"The crystal structure of the human hepatitis B virus capsid","volume":"3","author":"Wynne","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.antiviral.2020.104917_bib143","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.1254083","article-title":"Virology. Response to Comment on \"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"344","author":"Xia","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2020.104917_bib144","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","article-title":"Interferon-gamma and tumor necrosis factor-alpha produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis","volume":"150","author":"Xia","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2020.104917_bib145","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"10.1016\/j.antiviral.2020.104917_bib146","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/hep.30514","article-title":"Direct Inhibition of Hepatitis B e Antigen by Core Protein Allosteric Modulator","volume":"70","author":"Yan","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104917_bib147","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007690","article-title":"Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection","volume":"15","author":"Yang","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2020.104917_bib148","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/acsinfecdis.8b00337","article-title":"Treatment of chronic hepatitis B virus infection using small molecule modulators of nucleocapsid assembly: recent advances and perspectives","volume":"5","author":"Yang","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104917_bib149","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.antiviral.2015.11.004","article-title":"Effect of a hepatitis B virus inhibitor, NZ-4, on capsid formation","volume":"125","author":"Yang","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104917_bib150","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1128\/jvi.68.1.338-345.1994","article-title":"Capsid assembly and involved function analysis of twelve core protein mutants of duck hepatitis B virus","volume":"68","author":"Yang","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib151","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1128\/jvi.65.5.2327-2331.1991","article-title":"Phosphorylation of hepatitis B virus precore and core proteins","volume":"65","author":"Yeh","year":"1991","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2020.104917_bib152","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S0618-8278(19)30962-4","article-title":"Safety, antiviral activity, and pharmacokinetics of a novel hepatitis B virus capsid assembly modulator, JNJ-56136379, in Asian and non-Asian patients with chronic hepatitis B","volume":"70","author":"Yogaratnam","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2020.104917_bib153","article-title":"3.5A cryoEM structure of hepatitis B virus core assembled from full-length core protein","volume":"8","author":"Yu","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2020.104917_bib154","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1128\/JVI.73.7.5731-5740.1999","article-title":"The mechanism of an immature secretion phenotype of a highly frequent naturally occurring missense mutation at codon 97 of human hepatitis B virus core antigen","volume":"73","author":"Yuan","year":"1999","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.antiviral.2020.104917_bib155","article-title":"The second-generation hepatitis B virus (HBV) core inhibitor (CI) ABI-H2158 is associated with potent antiviral activity in a 14-day monotherapy study in HBeAg-positive patients with chronic hepatitis B (CHB)","volume":"70","author":"Yuen","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.antiviral.2020.104917_bib156","article-title":"Final results of a phase 1b 28-day study of abi-H0731, A novel core inhibitor, in non-cirrhotic viremic subjects with chronic HBV","volume":"68","author":"Yuen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104917_bib157","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S2468-1253(19)30346-2","article-title":"Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial","volume":"5","author":"Yuen","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.antiviral.2020.104917_bib158","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1053\/j.gastro.2018.12.023","article-title":"Antiviral activity, safety, and pharmacokinetics of capsid assembly modulator NVR 3-778 in patients with chronic HBV infection","volume":"156","author":"Yuen","year":"2019","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.antiviral.2020.104917_bib159","article-title":"First clinical experience with RNA interference-based triple combination therapy in chronic hepatitis B: JNJ-3989, JNJ-6379 and a nucleos(t)ide analogue","volume":"70","author":"Yuen","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.antiviral.2020.104917_bib160","article-title":"Analysis of factors influencing the efficacy and safety of GLS4 treatment of patients with chronic hepatitis B","volume":"70","author":"Zhang","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104917_bib161","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1128\/JVI.73.5.3616-3622.1999","article-title":"Enrichment of a precore-minus mutant of duck hepatitis B virus in experimental mixed infections","volume":"73","author":"Zhang","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib162","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01686-19","article-title":"A first-in-human trial of GLS4, a novel inhibitor of hepatitis B virus capsid assembly, following single- and multiple-ascending-oral-dose studies with or without ritonavir in healthy adult volunteers","volume":"64","author":"Zhao","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104917_bib163","doi-asserted-by":"crossref","DOI":"10.1002\/hep.31408","article-title":"Have the starting lineup of five for HBV cccDNA synthesis been identified?","author":"Zhao","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2020.104917_bib164","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02139-17","article-title":"Hepatitis B virus core protein dephosphorylation occurs during pregenomic RNA encapsidation","volume":"92","author":"Zhao","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104917_bib165","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.virol.2005.07.030","article-title":"Suppression of hepatitis B virus replication by SRPK1 and SRPK2 via a pathway independent of the phosphorylation of the viral core protein","volume":"342","author":"Zheng","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2020.104917_bib166","doi-asserted-by":"crossref","first-page":"42374","DOI":"10.1038\/srep42374","article-title":"Heteroaryldihydropyrimidine (HAP) and sulfamoylbenzamide (SBA) inhibit hepatitis B virus replication by different molecular mechanisms","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2020.104917_bib167","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/jmr.754","article-title":"Theoretical aspects of virus capsid assembly","volume":"18","author":"Zlotnick","year":"2005","journal-title":"J. Mol. Recogn."},{"key":"10.1016\/j.antiviral.2020.104917_bib168","doi-asserted-by":"crossref","first-page":"9556","DOI":"10.1073\/pnas.94.18.9556","article-title":"Localization of the C terminus of the assembly domain of hepatitis B virus capsid protein: implications for morphogenesis and organization of encapsidated RNA","volume":"94","author":"Zlotnick","year":"1997","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.antiviral.2020.104917_bib169","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tim.2010.11.003","article-title":"Virus assembly, allostery and antivirals","volume":"19","author":"Zlotnick","year":"2011","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2020.104917_bib170","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.antiviral.2015.06.020","article-title":"Core protein: a pleiotropic keystone in the HBV lifecycle","volume":"121","author":"Zlotnick","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104917_bib171","series-title":"Patients with Chronic Hepatitis B (CHB), Hepatology","first-page":"47A","article-title":"Safety, pharmacokinetics and antiviral activity of a novel hepatitis B virus (HBV) capsid assembly modulator, JNJ-56136379","author":"Zoulim","year":"2018"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354220303314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:33:36Z","timestamp":1759062816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354220303314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":170,"alternative-id":["S0166354220303314"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104917","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104917","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104917"}}